SonALAsense
Berkeley, CA
SonALAsense develops SDT (Sonodynamic Therapy) intended to turn glioblastoma multiforme (GBM) patients into cancer survivors. It utilizes MRI-guided focused ultrasound (the device) in combination with aminolevulinic acid (a drug) to selectively target and kill tumor cells. Their use of an MRI-guided focused ultrasound device with ALA is a truedrug-device combination, where both the drug and the device are required for a therapeutic effect. SDT has a well-elucidated mechanism of action (creation of reactive oxygen species). The company was founded in 2019 and is based in Berkeley, California.
sonalasense.comCompany Details
Founded
- 2019
Employees
- Between 5 - 20 employees
Raised
- $67,093,184
Headquarters Location
- Berkeley, CA
Public
- No
Acquired
- No
CEO
Mark De Souza
Founders
- Stuart Marcus
Company Collections
These are collections SonALAsense is a part of. Click on the collection name to view similar companies.
SonALAsense's Industries
SonALAsense's Tech Stack
SonALAsense Headquarters Location
Total Amount Raised: $67,093,184
SonALAsense Funding Rounds
Grant
$46,000,000
Grant Investors
Advanced Research Projects Agency for Health (ARPA-H)Series B
$20,093,202
Series B Investors
K4 Forum Mumbai NetworkDebt Financing
$999,980
SonALAsense Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on SonALAsense.